Peptide T: Clinical Trials

2 trials of Peptide T, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Peptide T: new trials by email Literature Review of Peptide T trials Research Report on Peptide T

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients.
Peptide T - HIV Infections
Phase 1CompletedNational Institute of Mental Health (NIMH)301988-01-012015-03-03
A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).
Peptide T - HIV Infections, Cognition Disorders
Phase 1CompletedNational Institute of Mental Health (NIMH)61988-01-012015-03-02

Conditions studied

Acquired Immunodeficiency Syndrome (2)  ·  HIV Infections (2)  ·  AIDS-Related Complex (1)  ·  Cognition Disorders (1)

Sponsors

National Institute of Mental Health (NIMH) (2)

Countries

United States (2)

Top investigators

Bridge TP (2)